Fundz

Ikerian raised $8M in the first close of its Series B funding led by Sanoptis to enhance its AI solutions for ophthalmology and optometry care.

PRIVATEOct 16, 2024

Amount Raised

$8 Million

Round Type

Series B

BernBiotechnologySoftwareHealth CareArtificial IntelligenceMedical

Investors

Thinc VenturesZürcher KantonalbankVerve VenturesSanoptis

Description

Ikerian and its subsidiary, RetinAI, based in Bern, Switzerland, raised $8M in the first close of its Series B funding. The funds will be used for the continued development and commercial rollout of its AI models and to improve automation and data connectivity in healthcare.

Quick answer

Ikerian raised $8 Million in a Series B round, dated October 16, 2024. Investors: Thinc Ventures, Zürcher Kantonalbank, Verve Ventures and Sanoptis. Ikerian is based in Bern, Bern, Switzerland.

How much did Ikerian raise?
Ikerian raised $8 Million in a Series B round on October 16, 2024.
Who invested in Ikerian?
Thinc Ventures, Zürcher Kantonalbank, Verve Ventures and Sanoptis are named as investors in this round.
What does Ikerian do?
Ikerian AG was formerly known as RetinAI Medical AG.
Where is Ikerian based and how big is it?
Ikerian is based in Bern, Bern, Switzerland. Fundz records about 12 employees.
Who are the decision-makers at Ikerian?
Fundz holds 1 contact at Ikerian. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as Ikerian that raised within 45 days of this round, from Fundz verified event records.

  • Ligence raised $3.2M (Seed) on November 13, 2024.
  • Pharos raised $5M (Seed) on October 25, 2024.
  • Shuttle Pharmaceutical Holdings raised $790K (Seed) on October 14, 2024.
  • Laennec AI Limited raised an undisclosed amount (Pre-Seed) on November 25, 2024.
  • Chiron Health AI raised an undisclosed amount (Pre-Seed) on November 22, 2024.
  • OneCell Diagnostics raised $16M (Series A) on November 21, 2024.

Who to call at Ikerian, and when

A new round usually means Ikerian is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ikerian raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ikerian, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ikerian. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ikerian

Location

Bern, Bern, Switzerland

About

Ikerian AG was formerly known as RetinAI Medical AG. Ikerian is a company on a mission to enable the right decisions sooner in healthcare. By harmonizing and aggregating unstructured medical data at scale, Ikerian creates a frictionless and open data ecosystem that enhances the understanding of patients' diseases and outcomes, ultimately driving better healthcare decisions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ikerian raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Ikerian's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Ikerian raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.